Adeel Amir
Family Medicine · North Tonawanda, NYNPI 1558712489
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 162 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 16.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,161 and has fallen 52.6% since, to $550 in 2022.
Across 162 payments — averaging $16.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$429
- Boehringer Ingelheim$340
- AstraZeneca$279
- GSK$244
- Gilead$189
- Kowa Pharmaceuticals America, Inc.$186
- plus $1K from 18 others
What the payments were for
- Food & beverage$2,669100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 28 | $429 |
| Boehringer Ingelheim | 22 | $340 |
| AstraZeneca | 20 | $279 |
| GSK | 16 | $244 |
| Gilead | 8 | $189 |
| Kowa Pharmaceuticals America, Inc. | 9 | $186 |
| Johnson & Johnson | 8 | $129 |
| Amarin Pharma, Inc. | 7 | $123 |
| AbbVie(2 entities) | 7 | $118 |
| Amgen | 7 | $116 |
| Novo Nordisk | 7 | $93 |
| E.r. Squibb & Sons, L.L.C. | 3 | $57 |
| Pfizer | 2 | $52 |
| Novartis | 3 | $47 |
| Bayer | 2 | $38 |
| Biohaven Pharmaceuticals, Inc. | 2 | $37 |
| Esperion Therapeutics, Inc. | 2 | $35 |
| Upsher-smith Laboratories LLC | 2 | $34 |
| Bausch Health US, LLC | 2 | $33 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $18 |
| Nevro Corp. | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
How this compares
$2,669 in reported general payments places this provider in the 80th percentile of 4,321 family medicine providers in New York.
Other family medicine in North Tonawanda
- Louis BonavitaEast Syracuse$674K
- Martin MahoneyBuffalo$520K
- Scott BrehautClinton$514K
- David St PeterSaratoga Springs$395K
- Matthew PabisNew York$222K
- Rajveer SachdevPomona$211K
- Eric SchnakenbergHalfmoon$190K
- James NorthGlens Falls$186K
- Eric BatesNew York$171K
- Alexander BlinskiNew York$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.